A phase IIb, multicenter, randomized, double-blind trial evaluating combined oral fecal microbiotherapy MaaT033 for preventing complications of allogeneic hematopoietic stem cell transplantation. (PHOEBUS Trial)
CLINICAL TRIAL WITH MEDICINES
Clinical trial information
- Promoter: ICON CLINICAL RESEARCH LTD
- Phase: II
- Execution start: 21/02/2024
- End of execution: 30/06/2027
- PI: MANUEL JURADO CHACON
